(Q80201001)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Effects of PYY[3-36] in rodent models of diabetes and obesity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

R A Pittner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

C X Moore

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

S P Bhavsar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

B R Gedulin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

P A Smith

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

C M Jodka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

D G Parkes

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

J R Paterniti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

V P Srivastava

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

A A Young

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

963-971

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

Distribution and postprandial release of porcine peptide YY.

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Human distribution and release of a putative new gut hormone, peptide YY

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Neuropeptide Y (NPY)-induced feeding behavior in female rats: comparison with human NPY ([Met17]NPY), NPY analog ([norLeu4]NPY) and peptide YY.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Peptide YY (PYY), a potent orexigenic agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Role of the Y5 neuropeptide Y receptor in feeding and obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Inhibition of food intake in obese subjects by peptide YY3-36

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Gut hormone PYY(3-36) physiologically inhibits food intake

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Neuropeptide Y inhibits estrous behavior and stimulates feeding via separate receptors in Syrian hamsters.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Autoradiographic distribution of [125I]Leu31,Pro34]PYY and [125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Area postrema lesions disrupt food intake induced by cerebroventricular infusions of 5-thioglucose in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Autoradiographic localization of peptide YY and neuropeptide Y binding sites in the medulla oblongata

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Neuropeptide Y receptor binding sites in rat brain: differential autoradiographic localizations with 125I-peptide YY and 125I-neuropeptide Y imply receptor heterogeneity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Peripheral peptide YY induces c-fos-like immunoreactivity in the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Central and peripheral regulation of gastric acid secretion by peptide YY

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Area postrema lesion alters the effects of peptide YY on 2-DG-stimulated pancreatic exocrine secretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

PYY inhibits CCK-stimulated pancreatic secretion through the area postrema in unanesthetized rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Identification and characterization of the emetic effects of peptide YY

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

The neuroanatomical axis for control of energy balance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Peptide YY release by fatty acids is sufficient to inhibit gastric emptying in dogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Effects of peptide YY and neuropeptide Y on gastric emptying in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Effect of peptide YY on gastric, pancreatic, and biliary function in humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Inhibition of gastric acid secretion by peptide YY is independent of gastric somatostatin release in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Peptide-YY, a new partner in the negative feedback control of pancreatic secretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Reduction of food intake in rats by intraperitoneal injection of low doses of amylin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Pramlintide: an agent for glycemic control plus weight control?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

The Diabetic Zucker Fatty Rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802696

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0802696

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15197409%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference